247
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Synchronized release of Doxil and Nutlin-3 by remote degradation of polysaccharide matrices and its possible use in the local treatment of colorectal cancer

, , , , , & show all
Pages 859-873 | Received 02 Jul 2011, Accepted 07 Sep 2011, Published online: 15 Nov 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Shailendra Kapoor. (2013) The emerging anti-proliferative role of Nutlin-3 in the pathogenesis of systemic malignancies. Cancer Biology & Therapy 14:1, pages 5-5.
Read now

Articles from other publishers (7)

Qianyu Wang, Xiaofei Shen, Gang Chen & Junfeng Du. (2022) Drug Resistance in Colorectal Cancer: From Mechanism to Clinic. Cancers 14:12, pages 2928.
Crossref
Flaviana Marzano, Mariano Francesco Caratozzolo, Graziano Pesole, Elisabetta Sbisà & Apollonia Tullo. (2021) TRIM Proteins in Colorectal Cancer: TRIM8 as a Promising Therapeutic Target in Chemo Resistance. Biomedicines 9:3, pages 241.
Crossref
Racheli Sharon Gabbay, Ron S. Kenett, Roberto Scaffaro & Abraham Rubinstein. (2018) Synchronizing the release rates of salicylate and indomethacin from degradable chitosan hydrogel and its optimization by definitive screening design. European Journal of Pharmaceutical Sciences 125, pages 102-109.
Crossref
Tohru Yamada, Tapas K. Das Gupta & Craig W. Beattie. (2016) p28-Mediated Activation of p53 in G2–M Phase of the Cell Cycle Enhances the Efficacy of DNA Damaging and Antimitotic Chemotherapy. Cancer Research 76:8, pages 2354-2365.
Crossref
Erin K. Crane, Suet-Yan Kwan, Daisy I. Izaguirre, Yvonne T. M. Tsang, Lisa K. Mullany, Zhifei Zu, JoAnne S. Richards, David M. Gershenson & Kwong-Kwok Wong. (2015) Nutlin-3a: A Potential Therapeutic Opportunity for TP53 Wild-Type Ovarian Carcinomas. PLOS ONE 10:8, pages e0135101.
Crossref
Xiao-Lan Li. (2015) p53 mutations in colorectal cancer- molecular pathogenesis and pharmacological reactivation . World Journal of Gastroenterology 21:1, pages 84.
Crossref
Qi Zhang, Shelya X. Zeng & Hua Lu. 2014. Mutant p53 and MDM2 in Cancer. Mutant p53 and MDM2 in Cancer 281 319 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.